A detailed history of Macquarie Group LTD transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 123,603 shares of A stock, worth $16.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
123,603
Previous 122,418 0.97%
Holding current value
$16.5 Million
Previous $15.9 Million 15.65%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$125.42 - $148.48 $148,622 - $175,948
1,185 Added 0.97%
123,603 $18.4 Million
Q2 2024

Aug 09, 2024

SELL
$129.63 - $154.64 $135 Million - $161 Million
-1,043,369 Reduced 89.5%
122,418 $15.9 Million
Q1 2024

May 14, 2024

SELL
$128.12 - $149.31 $13.7 Million - $16 Million
-106,964 Reduced 8.4%
1,165,787 $170 Million
Q4 2023

Feb 14, 2024

BUY
$101.17 - $139.82 $1.61 Million - $2.22 Million
15,893 Added 1.26%
1,272,751 $177 Million
Q3 2023

Nov 14, 2023

BUY
$109.73 - $128.47 $4.62 Million - $5.41 Million
42,144 Added 3.47%
1,256,858 $141 Million
Q2 2023

Aug 14, 2023

BUY
$114.69 - $141.28 $8.37 Million - $10.3 Million
72,963 Added 6.39%
1,214,714 $146 Million
Q1 2023

May 15, 2023

BUY
$131.13 - $159.06 $22.9 Million - $27.8 Million
175,006 Added 18.1%
1,141,751 $158 Million
Q4 2022

Feb 21, 2023

SELL
$125.64 - $157.68 $1.83 Million - $2.29 Million
-14,549 Reduced 1.48%
966,745 $145 Million
Q3 2022

Nov 14, 2022

BUY
$115.11 - $142.29 $289,271 - $357,574
2,513 Added 0.26%
981,294 $119 Million
Q2 2022

Aug 15, 2022

SELL
$112.71 - $135.93 $4.22 Million - $5.09 Million
-37,453 Reduced 3.69%
978,781 $116 Million
Q1 2022

May 16, 2022

SELL
$126.0 - $156.48 $1.82 Million - $2.26 Million
-14,412 Reduced 1.4%
1,016,234 $134 Million
Q4 2021

Feb 11, 2022

SELL
$147.95 - $164.3 $2.88 Million - $3.19 Million
-19,435 Reduced 1.85%
1,030,646 $165 Million
Q3 2021

Nov 12, 2021

SELL
$147.58 - $179.28 $6.63 Million - $8.05 Million
-44,891 Reduced 4.1%
1,050,081 $165 Million
Q2 2021

Aug 13, 2021

BUY
$127.69 - $148.81 $113 Million - $132 Million
887,356 Added 427.4%
1,094,972 $162 Million
Q1 2021

May 14, 2021

SELL
$114.99 - $130.12 $678,670 - $767,968
-5,902 Reduced 2.76%
207,616 $26.4 Million
Q4 2020

Feb 16, 2021

SELL
$100.01 - $119.3 $1.6 Million - $1.91 Million
-16,033 Reduced 6.98%
213,518 $25.3 Million
Q3 2020

Nov 13, 2020

SELL
$88.11 - $103.42 $1.3 Million - $1.53 Million
-14,777 Reduced 6.05%
229,551 $23.2 Million
Q2 2020

Aug 11, 2020

SELL
$68.92 - $91.14 $358,866 - $474,565
-5,207 Reduced 2.09%
244,328 $21.6 Million
Q1 2020

May 15, 2020

SELL
$63.37 - $90.13 $2.02 Million - $2.88 Million
-31,909 Reduced 11.34%
249,535 $17.9 Million
Q4 2019

Feb 14, 2020

BUY
$72.49 - $85.45 $13 Million - $15.4 Million
179,994 Added 177.42%
281,444 $24 Million
Q3 2019

Nov 14, 2019

BUY
$65.59 - $78.07 $3,279 - $3,903
50 Added 0.05%
101,450 $7.77 Million
Q2 2019

Aug 14, 2019

SELL
$66.89 - $81.94 $329,098 - $403,144
-4,920 Reduced 4.63%
101,400 $7.57 Million
Q1 2019

May 15, 2019

SELL
$63.27 - $82.0 $359,373 - $465,760
-5,680 Reduced 5.07%
106,320 $8.55 Million
Q4 2018

Feb 15, 2019

SELL
$61.13 - $74.67 $256,746 - $313,614
-4,200 Reduced 3.61%
112,000 $7.56 Million
Q3 2018

Nov 15, 2018

SELL
$61.25 - $71.13 $171,010 - $198,594
-2,792 Reduced 2.35%
116,200 $8.2 Million
Q2 2018

Aug 14, 2018

BUY
$61.14 - $69.55 $36,684 - $41,730
600 Added 0.51%
118,992 $7.36 Million
Q1 2018

May 11, 2018

SELL
$65.05 - $74.82 $1.24 Million - $1.42 Million
-19,000 Reduced 13.83%
118,392 $7.92 Million
Q4 2017

Feb 15, 2018

SELL
$64.87 - $70.59 $710,845 - $773,525
-10,958 Reduced 7.39%
137,392 $9.23 Million
Q3 2017

Nov 08, 2017

BUY
$58.57 - $66.17 $8.69 Million - $9.82 Million
148,350
148,350 $9.52 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.